# Byron Hewett

> Byron Hewett is a Boulder-based executive, cofounder and adviser whose career spans established corporations, emerging research businesses and company boards. A former SomaLogic CEO and Brava Diagnostics cofounder, he works as a fractional CEO with General Inception and became chair of the Colorado BioScience Association board in March 2026.

- **Role:** Fractional CEO at General Inception; Board Chair at Colorado BioScience Association
- **Organizations:** General Inception, Colorado BioScience Association, Nomic Bio, Brava Diagnostics, LightDeck Diagnostics, SomaLogic, BioBehavioral Diagnostics, Immunicon, Qiagen, Bayer, Chiron, BioCircuits, Abbott, HepQuant, Darwin Biosciences, AOA Dx, ExOcular Dx
- **Education:** B.S., Commerce, University of Virginia, McIntire School of Commerce, Masters in Management (described as MBA in later profiles), Northwestern University, J.L. Kellogg Graduate School of Management
- **Known for:** Four-time CEO, described in his 2023 conference biography as having sold two companies and merged another., Built SomaLogic commercial operations during his 2013-2017 CEO tenure., Cofounded Brava Diagnostics.

## Career timeline

- **2005** — Named president and COO of Immunicon; subsequently served as CEO.
- **2009** — Became full-time executive chairman of BioBehavioral Diagnostics in March, according to his 2010 interview.
- **2013** — Appointed CEO and board member of SomaLogic, succeeding founder Larry Gold.
- **2016** — Led SomaLogic during partnership expansion and an announced debt-and-equity financing arrangement of up to $60.5 million.
- **2017** — Stepped down as SomaLogic CEO in April; Alister Reynolds succeeded him.
- **2020** — Joined Colorado BioScience Association board as Brava Diagnostics founder and CEO.
- **2022** — Began fractional CEO role at General Inception, according to his public professional profile.
- **2023** — Nomic publicly announced his board appointment in June; served as CBSA strategic planning committee chair.
- **2026** — Became Colorado BioScience Association board chair in March.

## Achievements

- Four-time CEO, described in his 2023 conference biography as having sold two companies and merged another.
- Built SomaLogic commercial operations during his 2013-2017 CEO tenure.
- Cofounded Brava Diagnostics.
- Named with Larry Gold as a 2016 regional EY Entrepreneur Of The Year finalist.
- Appointed Colorado BioScience Association board chair in March 2026.

## Latest updates

- **2026-03** — Colorado BioScience Association announced Hewett as its new board chair, alongside vice chair Robin Harper Cowie.

## Links

- Website: https://www.generalinception.com/team
- LinkedIn: https://www.linkedin.com/in/byron-hewett-74aabb7

---

Profile page: https://yespress.io/byron-hewett
Published by YesPress — https://yespress.io
Last updated: 2026-10-09